FDA NDC Directory · JSON-LD · Markdown

FASENRA

NDC 0310-1830 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameBenralizumab
Labeler / ManufacturerAstraZeneca Pharmaceuticals LP
Marketing categoryBiologic License Application · App BLA761070
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsBENRALIZUMAB (30 mg/mL)
Marketing started20191004
Package count2

External sources

Source: openFDA. Public-domain (CC0).